News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Tennessee
Mergers & acquisitions
Crown Laboratories to Buy Botox Rival Revance Therapeutics for $924M
The acquisition announced Monday will give Crown access to Revance’s Daxxify, a competitor to AbbVie’s Botox, which is indicated for frown lines and for cervical dystonia.
August 13, 2024
·
2 min read
·
Tristan Manalac
PRESS RELEASES
Press Releases
Enigma Biomedical USA, Inc. Announces Candidate Selection of Novel 4R Tau PET Imaging Biomarkers
March 21, 2025
·
2 min read
Press Releases
Currax Secures Reliable and Consistent Supply of CONTRAVE®/MYSIMBA with FDA Approval for Second Manufacturing Site
March 20, 2025
·
8 min read
Press Releases
Currax Secures Reliable and Consistent Supply of CONTRAVE®/MYSBIMA with FDA Approval for Second Manufacturing Site
March 20, 2025
·
8 min read
Press Releases
NHI Announces $46.3 Million Senior Housing Investment
March 17, 2025
·
7 min read
Press Releases
FOXO TECHNOLOGIES INC. PROVIDES UPDATE ON ITS BEHAVIORAL HEALTH SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC.
March 12, 2025
·
3 min read
Press Releases
Currax Pharmaceuticals: Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA®
March 12, 2025
·
8 min read
Press Releases
Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®
March 11, 2025
·
6 min read
Press Releases
Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025
March 5, 2025
·
2 min read
Press Releases
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
March 4, 2025
·
13 min read
Press Releases
Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023
March 4, 2025
·
4 min read
Press Releases
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2024 Results; Sets 2025 Guidance
March 4, 2025
·
20 min read
Press Releases
Harrow to Report Fourth Quarter and Year-End 2024 Financial Results After Market Close on March 17, 2025
March 3, 2025
·
1 min read
Press Releases
Daxor Expands Blood Volume Analysis Services at Major Midwest Healthcare Center
March 3, 2025
·
3 min read
Press Releases
Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals
February 27, 2025
·
3 min read
Press Releases
Crown Laboratories Announces Appointment of Adelle Walker as Chief Marketing Officer, Aesthetics
February 27, 2025
·
3 min read
Press Releases
Aegis Sciences Corporation Launches MedProtectCDM to Transform Medication Adherence and Safety Monitoring for Chronic Conditions
February 25, 2025
·
4 min read
Press Releases
Daxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025
February 20, 2025
·
4 min read
Press Releases
Daxor to Exhibit at World’s Largest Critical Care Conference
February 19, 2025
·
3 min read
Press Releases
Surgery Partners, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call Details
February 18, 2025
·
1 min read
Press Releases
New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care
February 14, 2025
·
3 min read
